Iambic signs AbbVie deal, releases next generation of Enchant model
Iambic Therapeutics released the next generation of one of its main AI models, while signing an R&D partnership with the pharma giant AbbVie. Founded in 2019, the San Diego-headquartered biotech has
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.